28 results on '"Cucurull, Marc"'
Search Results
2. Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients
3. Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
4. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
5. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
6. Lung cancer patients with COVID-19 in Spain: GRAVID study
7. Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
8. Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C
9. Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery
10. Prognostic factors in patients with uterine sarcoma: the SARCUT study
11. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
12. Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study.
13. Therapeutic options for lung cancer with ALK or ROS1 (+) rearrangement. First line and progression management
14. Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients
15. Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV ‐2 mRNA ‐1237 vaccine in patients with solid tumors
16. Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study
17. Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer
18. Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
19. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
20. Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors.
21. Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study.
22. Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
23. Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?
24. Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small-cell lung cancer and no other actionable oncogenic driver
25. Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen
26. Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution
27. Prognostic value of monocyte to lymphocyte ratio (MLR) in epithelial ovarian cancer (EOC).
28. Clinical algorithm to predict who may benefit from CDK4/6 inhibitors in patients (p) with estrogen receptor positive and HER-2 negative (ER+/Her2-) metastatic breast cancer (MBC).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.